Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Increased
Reduced
Net increased
Funds Holding
2,888
Funds Holding Change
-10
Funds Holding Growth
-0.3%
Value
$932B
Holding in Top 10
1,273
Top 10 Change
-109
Top 10 Growth
-8%
Value Growth
-2%
New
85
Increased
1,294
Reduced
1,339
Closed
59
Capital Inflow
$26.1B
Capital Outflow
$31.8B
Net Capital Flow
-$5.65B
Capital Flow Change
+$643M
Calls
$12.1B
Puts
$14.3B
Net Calls
-$2.14B
Put/Call Ratio
1.18